N-Heterocyclic Carbenes as Ligands to 198Au(I)-Radiolabeled Compounds: A New Platform for Radiopharmaceutical Design
Open Access
- 13 August 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (16) , 17516-17526
Abstract
The radionuclide 198Au, with a half-life of 2.7 days, emits γ radiation ideal for diagnostic purposes and generates β– particles suitable for effective cancer radiotherapy, making it a perfect nuclide for “theranostics”. However, the application of coordination compounds of Au(I)/Au(III) in medicine is limited by their instability in vivo. Here, we explore N-heterocyclic carbene (NHC) organometallic chemistry to stabilize 198Au(I) in radiopharmaceuticals. Thus, Au(I) NHC compounds featuring different scaffolds were selected for 198Au radiolabeling. Eventually, two compounds featuring imidazole (AuNHC-1) and theophylline (AuTMX2) scaffolds were successfully radiolabeled (radiochemical purity = 92.9% and 40.2%, respectively). Instead, two peptidic Au(I) benzimidazolylidene derivatives, capable of blood–brain barrier translocation in vitro, were subjected to ligand exchange reactions under the applied radiolabeling conditions. The obtained proof-of-concept results showed that NHCs are suitable ligands to achieve isotope exchange in Au(I) complexes. Overall, our work reveals the still untapped potential of organometallic chemistry in radiopharmaceutical design.Keywords
All Related Versions
Funding Information
- HORIZON EUROPE European Innovation Council (101129886)
This publication has 53 references indexed in Scilit:
- Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery SystemsAngewandte Chemie International Edition, 2023
- Synthesis and antiproliferative study of phosphorescent multimetallic Re(I)/Au(I) complexes containing fused imidazo[4,5‐f]‐1,10‐phenanthroline coreApplied Organometallic Chemistry, 2022
- Gold(I) and Gold(III) N‐Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin ReductaseChemMedChem, 2021
- Radiolabeling of Gold Nanocages for Potential Applications in Tracking, Diagnosis, and Image‐Guided TherapyAdvanced Healthcare Materials, 2021
- 124I Radiolabeling of a AuIII‐NHC Complex for In Vivo Biodistribution StudiesAngewandte Chemie International Edition, 2020
- Water‐Soluble N‐Heterocyclic Carbene‐Protected Gold Nanoparticles: Size‐Controlled Synthesis, Stability, and Optical PropertiesAngewandte Chemie International Edition, 2017
- Gold Nanoparticles Doped with 199Au Atoms and Their Use for Targeted Cancer Imaging by SPECTAdvanced Healthcare Materials, 2016
- Biodistribution of a potential chemotherapeutic, dinuclearbisphosphinogold(I) dithiocarbamate, as determined by its 198Au radiolabelled analogueJournal of Radioanalytical and Nuclear Chemistry, 2014
- New Gold(I) Organometallic Compounds with Biological Activity in Cancer CellsEuropean Journal of Inorganic Chemistry, 2014
- Chemistry in Environmentally Benign Media, 8 Hydroxymethyl Functionalized Phosphanes as Building Blocks to new Water‐Soluble Gold(I) Complexes ‐ synthesis, Characterization, and X‐ray crystal Structures of Novel Tetrahedral [Au{P(CH2OH)3}4]+ and Trigonal Planar [Au(Ph2PCH2OH)3]+ Gold (I) ComplexesEuropean Journal of Inorganic Chemistry, 1997